Qi Wu
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
- MicroRNA in disease regulation
- Immunology top 5%
- Immune cells in cancer
Papers in
-
- Epigenetics and DNA Methylation 9
- Oncology 23
- Cancer Immunotherapy and Biomarkers 6
- Cancer Cells and Metastasis 5
- Co-authors
- Shengrong Sun (32 shared papers)Si Sun (25 shared papers)Juanjuan Li (16 shared papers)Juanjuan Li (9 shared papers)Zhiyu Li (11 shared papers)Yang Ouyang (2 shared papers)Guo‐Qing Zhu (12 shared papers)Si Sun (3 shared papers)
- Journals
- Cell Death and Disease (7 papers)Cellular Signalling (5 papers)Signal Transduction and Targeted Therapy (4 papers)Frontiers in Oncology (4 papers)Oncotarget (3 papers)
- Partner nations
- ChinaFranceUnited States
In The Last Decade
Qi Wu
113 papers receiving 4.2k citations
Qi Wu's Hit Papers
Peers
Comparison fields: 5 of 137
- Cancer Research 869
- Immunology 751
- Oncology 800
- Molecular Biology 1.7k
- Pulmonary and Respiratory Medicine 603
Countries citing papers authored by Qi Wu
This map shows the geographic impact of Qi Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi Wu more than expected).
Fields of papers citing papers by Qi Wu
This network shows the impact of papers produced by Qi Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi Wu. The network helps show where Qi Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Qi Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 119 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cancer-associated adipocytes: key players in breast cancer progression Hit paper breakdown → | 2019 | 343 |
| 2 | Chalcone Derivatives: Role in Anticancer Therapy Hit paper breakdown → | 2021 | 277 |
| 3 | 2017 | 252 | |
| 4 | 2017 | 206 | |
| 5 | 2018 | 190 | |
| 6 | Emerging phagocytosis checkpoints in cancer immunotherapy Hit paper breakdown → | 2023 | 188 |
| 7 | 2019 | 141 | |
| 8 | 2022 | 110 | |
| 9 | 2020 | 109 | |
| 10 | 2022 | 108 | |
| 11 | 2018 | 80 | |
| 12 | 2019 | 78 | |
| 13 | 2020 | 77 | |
| 14 | 2003 | 75 | |
| 15 | 2003 | 74 | |
| 16 | 2021 | 73 | |
| 17 | 2021 | 67 | |
| 18 | 2020 | 60 | |
| 19 | 2021 | 58 | |
| 20 | 2020 | 52 |
About Qi Wu
Qi Wu is a scholar working on Molecular Biology, Oncology, Immunology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 119 papers that have together received 4.3k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (11 papers), Autophagy in Disease and Therapy (10 papers), Epigenetics and DNA Methylation (9 papers), Cancer, Hypoxia, and Metabolism (8 papers), Immune cells in cancer (8 papers), Cancer Immunotherapy and Biomarkers (6 papers), Cancer Cells and Metastasis (5 papers) and Thyroid Cancer Diagnosis and Treatment (5 papers). The work is most often cited by research in Cancer Research (869 citations), Immunology (751 citations), Oncology (800 citations), Molecular Biology (1.7k citations) and Pulmonary and Respiratory Medicine (603 citations). Qi Wu has collaborated with scholars based in China, France and United States. Frequent co-authors include Shengrong Sun, Si Sun, Juanjuan Li, Juanjuan Li, Zhiyu Li, Yang Ouyang, Guo‐Qing Zhu, Si Sun, Fenyong Sun and Bei Li. Their work appears in journals such as Cell Death and Disease, Cellular Signalling, Signal Transduction and Targeted Therapy, Frontiers in Oncology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.